Editor's Note In this study from the Houston Methodist Research Institute, immediate-use steam sterilization (IUSS) using a Steris Amsco Evolution HC1500 PreVac Steam Sterilizer autoclave was performed on N95 masks. Masks were wrapped in paper-plastic sterilization peel pouches (Medical Action Industries 8” role, Ref 422R). A chemical indicator and biological…
Editor' Note The American College of Surgeons (ACS) on April 17 released a new document, “Local Resumption of Elective Surgery Guidance,” to help healthcare facilities prepare to resume elective surgery once COVID-19 has peaked in their area. The document includes four categories: COVID Awareness—addresses the community’s COVID-19 numbers, including prevalence,…
Editor's Note Among the actions announced April 15 by the Food & Drug Administration (FDA) in response to the COVID-19 pandemic are: Issuance of two new emergency use authorizations (EUAs) for serology tests, to detect for presence of coronavirus antibodies, to Ortho-Clinical Diagnostics, Inc, and Chembio Diagnostic systems, Inc. Issuance…
Editor's Note In this experimental study from Australia, researchers investigate the effect of ventilator splitting on system variables (ie, inspiratory pressure, flow, and volume) and the possibility of different ventilation targets for each limb. Connecting two patients to the same ventilator presents many challenges: ventilation requirements are different for different…
Editor's Note Safe Flight Instrument Corporation (White Plains, New York), a company that develops aircraft safety and performance technology, has developed the Quad/Vent Splitter that allows four patients to use one ventilator simultaneously, the April 13 Aviation International News Online reports. Using 3-D printing, the device has four independent ports…
Editor's Note The Food & Drug Administration (FDA) on April 7 issued an update on actions the agency has taken in its ongoing response to the COVID-19 pandemic. The actions include: a guidance for remote ophthalmic assessment and monitoring devices to facilitate patient care while reducing patient and healthcare provider…
Editor's Note Exscientia (Oxford, UK) has announced a joint initiative with Diamond Light Source (Oxforshire, UK) and Calibr (La Jolla, California), a division of Scripps Research, to use its artificial intelligence (AI) drug discovery platform to identify compounds that could become viable drugs for treatment of COVID-19, the April 2…
Editor's Note During the first 3 weeks of the COVID-19 outbreak in the Seattle area, the most common reasons for ICU admission were hypoxemic respiratory failure leading to mechanical ventilation and/or hypotension requiring vasopressor treatment, and mortality was high in these critically ill patients, this study finds. In this analysis…
Editor's Note In this study, researchers from NYU Grossman School of Medicine and the Courant Institute of Mathematical Sciences at New York University, in partnership with Wenzhou Central Hospital and Cangnan People’s Hospital in Wenzhou, China, developed an artificial intelligence (AI) framework that accurately predicted which patients newly infected with…
Editor's Note The Food & Drug Administration (FDA) on March 24 took action to increase US supplies in response to the COVID-19 pandemic by providing instructions to manufacturers importing personal protective equipment (PPE) and other devices. The instructions to manufacturers clarify the types of PPE and devices they can import…